IFF Honors Distinguished Academics Shaping the Future of Nutrition, Health and Biosciences
IFF Science Awards honor Dr. Carles Lerín and Prof. Jan Maarten van Dijl for contributions to nutrition, microbiome science and antimicrobial research
IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced the recipients of its IFF Science Awards, recognizing Dr. Carles Lerín of Institut de Recerca Sant Joan de Déu in Barcelona, Spain, and Prof. Jan Maarten van Dijl of the University Medical Center Groningen in Groningen, Netherlands, for their outstanding contributions to the fields of human health, nutrition and antimicrobial research. The IFF Science Awards honor individuals for their remarkable achievements in science, specifically within food, the microbiome, nutrition, health, biocatalysis and sustainability.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030622387/en/
Photo credit: Dr. Carles Lerín
“Breakthrough innovation thrives on collaboration. By partnering with world-class scientists and institutions, we accelerate the development of sustainable solutions that benefit our customers and the communities we serve,” said Casper Vroemen, chief R&D officer at IFF. “It’s a privilege to honor two exceptional researchers whose pioneering work embodies the spirit of scientific advancement and global partnership.”
The 2025 IFF Science Award honorees are:
- Dr. Carles Lerín
Institut de Recerca Sant Joan de Déu, Barcelona, Spain
School of Medicine, University of Vic - Central University of Catalonia (UVic-UCC)
Dr. Lerín is recognized for his pioneering research in human nutrition and health, with a focus on childhood and adolescent obesity, maternal and early-life nutrition, the microbiome, and metabolic disease. His work explores the critical links between early-life dietary patterns and long-term metabolic outcomes, integrating microbiome science to illuminate how nutrition shapes health trajectories. Notably, Dr. Lerín has advanced understanding of betaine’s role in gut and metabolic health, highlighting its potential to support healthy growth and resilience during key developmental stages. He is also celebrated for his science teaching, mentorship, and collaborative efforts across academia and industry.
- Prof. Jan Maarten van Dijl
University Medical Center Groningen (UMCG), Netherlands
Prof. van Dijl is a leading figure in molecular bacteriology, renowned for his groundbreaking research on microbial protein secretion and host-pathogen interactions. His innovative approaches have advanced the development of novel antimicrobial strategies, contributing to the fight against antibiotic resistance and deepening our understanding of infectious diseases. Prof. van Dijl’s work aligns with global health priorities and demonstrates sustained excellence and collaborative spirit.
Established in 1981, the Danisco Foundation supports research in food science, nutrition and health. Today, the IFF Science Awards continue this legacy and reflect IFF’s broader commitment to scientific advancement by recognizing researchers whose work contributes to knowledge and real-world impact. This year’s award includes a $35,000 prize. Award candidates are selected through a rigorous nomination process by IFF technical fellows, laureates and R&D leaders.
Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products — advancing wellness, delighting the senses and enhancing the human experience.Learn more at iff.com, LinkedIn, Instagram and Facebook.
© 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251030622387/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Canva Launches Creative Operating System30.10.2025 18:00:00 CET | Press release
Next era of Canva combines a supercharged Visual Suite, world-first design AI, and powerful tools to grow your brand Canva Design Model: World-first AI model that understands complexities and ingredients of design. AI Where You Work: Bring your imagination to life in every part of the design process, plus, a new design assistant. Video 2.0: A reimagined video editor makes professional and engaging content effortless. Canva Grow: Powerful marketing engine to ideate, create, distribute, and refine engaging ads to scale your brand. All-New Affinity: All-in-one app built by pro designers for pro designers, now forever free. Forms: Design interactive forms that can be added to any design for everything from RSVP forms to contact pages. Email Design: Design engaging emails with Canva’s drag-and-drop editor, then export to your platform of choice. Canva Code in Sheets: Seamlessly link interactive widgets with Canva Sheets to bring data to life in real time. Canva, the world’s only all-in-one
Svante Celebrates 18 Years of Carbon Management Innovation with Historic Milestones in 202530.10.2025 17:25:00 CET | Press release
Svante Technologies Inc. (Svante), a global leader in carbon capture and removal solutions, proudly marks its 18th anniversary this month, celebrating nearly two decades of pioneering industrial carbon management technology. This year has been one of the most transformative in Svante’s history, defined by bold innovation, strategic partnerships, and the commissioning of the world’s first commercial manufacturing facility for solid sorbent-based carbon capture and removal filters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030974500/en/ Founded in 2007 with a vision to revolutionize how the world manages carbon dioxide emissions, Svante has grown into a cornerstone of the global carbon management industry. In 2025, that vision took a monumental leap forward with the launch of the Redwood Facility in Burnaby, BC — a 141,000-square-foot Centre of Excellence for Carbon Capture and Removal. This first-of-its-kind manufactu
Ireland Unveils Seven New Halloween Experiences30.10.2025 15:00:00 CET | Press release
More celebrations than ever across the island of Ireland – the true Home of Halloween With seven brand-new Halloween hubs or experiences launching across the island this month, Ireland has truly become the ultimate destination to celebrate Halloween in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022209535/en/ Derry Halloween Festival, County Derry~Londonderry Ireland’s Halloween Season Rooted in the ancient Celtic festival of Samhain, Halloween originated in Ireland more than 2,000 years ago and, this year, the island of Ireland is expanding its celebration like never before. With over 340 events planned across the island to celebrate this year, Halloween in Ireland is fast becoming a bucket-list travel experience. Seven new Halloween hubs join existing flagship events across the island of Ireland including the Púca Festival in County Meath and Derry Halloween in Derry-Londonderry which together welcomed over 169
Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents30.10.2025 14:56:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of Staloral® Birch in children and adolescents with birch pollen-induced allergic rhino-conjunctivitis (ARC), with or without asthma, has successfully achieved its primary endpoint. The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without asthma, across 64 sites in 12 European countries and assessed the efficacy and safety of Staloral® birch 300IR daily maintenance dose administered pre-and co-seasonally over two consecutive birch pollen seasons. The YOBI study successfully met its primary endpoint, demonstrating the efficacy of Staloral® Birch in a paediatric population (5-17) with a 41% improvement in the ARC total combined score during the second pollen season compared to placebo. These results were highly statistically significant
Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers30.10.2025 14:00:00 CET | Press release
An Alliance to Combat Resistance: Debiopharm and NetTargets will collaborate to develop next-generation, dual-payload Antibody-Drug Conjugates (ADCs) designed to overcome acquired resistance mechanisms in difficult-to-treat cancers. AI-Powered Precision: The collaboration combines NetTargets' proprietary AI discovery platform—to identify synergistic drug pairings—with Debiopharm’s MLINK Duo technology for coordinated delivery of two distinct warheads on a single ADC. Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company dedicated to developing innovative therapies that respond to high unmet medical needs, today announced a strategic research collaboration with NetTargets (www.net-targets.com), a South Korean biotech company specializing in AI-enhanced systems biology for drug discovery, to rationally design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-generation Antibody-Drug Conjugates (ADCs). This allianc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom